GlycoMimetics’ Sickle Cell Candidate Nearly Ready For Hand-Over To Pfizer

Biotech focused on role of carbohydrates in biological processes completes Phase II program of lead candidate for sickle cell disease. Under a 2011 partnership, Pfizer takes over development of GMI-1070 in Phase III.